pentobarbital will minimize the extent or influence of alosetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Mysterious.

pentobarbital will reduce the extent or influence of theophylline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

buprenorphine transdermal and pentobarbital each maximize sedation. Stay away from or Use Alternate Drug. Limit use to people for whom alternative therapy possibilities are insufficient

pentobarbital will reduce the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Carefully. Take into consideration a rise in cannabidiol dosage (dependant on medical response and tolerability) when coadministered with a strong CYP3A4 inducer.

pentobarbital will reduce the level or influence of doxorubicin liposomal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.

Contraindicated (1)pentobarbital will minimize the level or effect of cariprazine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is to blame for the development and elimination of cariprazine's Lively metabolites.

pentobarbital will minimize the level or result of estradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

pentobarbital will reduce the extent or effect of aripiprazole by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

Check Carefully (one)pentobarbital will decrease the extent or influence of tadalafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will decrease the extent or influence of lapatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.

Se puede comunicar directamente con el centro click here de Handle de toxicología neighborhood llamando al número nacional gratuito Poison Assistance

pentobarbital will minimize the level or influence of ramelteon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Unidentified.

pentobarbital decreases levels of toremifene by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. CYP3A4 inducers enhance level of toremifene metabolism, decreasing the continuous-point out focus in serum.

pentobarbital will reduce the level or result of bosentan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Not known.